| Literature DB >> 32831166 |
Georgios Eleftheriou, Raffaella Butera, Mariapina Gallo, Andrea Giampreti, Lorella Faraoni, Maria Gioia Contessa, Giuseppe Bacis.
Abstract
Lacosamide, a new antiepileptic drug, acts at central nervous system level but may also affect the heart, increasing the risk of cardiac arrhythmias. Only few cases of lacosamide-induced cardiac dysrhythmia have been published. We report a case of several episodes of a life-threatening ventricular fibrillation requiring cardioversion following the first doses of lacosamide as adjunctive epilepsy treatment.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32831166 DOI： 10.5414/CP203813
Source DB: PubMed Journal: Int J Clin Pharmacol Ther ISSN： 0946-1965 Impact factor: 1.366